BTIM Corp. increased its position in shares of Danaher Co. (NYSE:DHR) by 3.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 258,809 shares of the conglomerate’s stock after buying an additional 9,666 shares during the period. BTIM Corp.’s holdings in Danaher were worth $34,168,000 at the end of the most recent quarter.
Several other institutional investors have also recently made changes to their positions in the company. American Research & Management Co. purchased a new position in shares of Danaher during the first quarter valued at $66,000. Palisade Asset Management LLC increased its stake in shares of Danaher by 36.9% during the first quarter. Palisade Asset Management LLC now owns 23,804 shares of the conglomerate’s stock valued at $3,143,000 after buying an additional 6,414 shares during the period. Flagship Harbor Advisors LLC increased its stake in shares of Danaher by 6.1% during the first quarter. Flagship Harbor Advisors LLC now owns 7,741 shares of the conglomerate’s stock valued at $1,022,000 after buying an additional 442 shares during the period. Paragon Capital Management LLC purchased a new position in shares of Danaher during the first quarter valued at $120,000. Finally, First Command Financial Services Inc. purchased a new position in Danaher in the first quarter valued at about $117,000. Hedge funds and other institutional investors own 77.59% of the company’s stock.
Shares of NYSE DHR opened at $128.18 on Wednesday. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.47 and a quick ratio of 1.07. The stock has a market capitalization of $93.40 billion, a price-to-earnings ratio of 28.36, a price-to-earnings-growth ratio of 2.41 and a beta of 1.04. Danaher Co. has a fifty-two week low of $94.59 and a fifty-two week high of $134.50.
Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, January 29th. The conglomerate reported $1.28 earnings per share for the quarter, topping the consensus estimate of $1.27 by $0.01. The business had revenue of $5.40 billion during the quarter, compared to the consensus estimate of $5.33 billion. Danaher had a return on equity of 11.64% and a net margin of 13.33%. The company’s quarterly revenue was up 6.2% on a year-over-year basis. During the same quarter last year, the company earned $1.19 earnings per share. On average, equities analysts anticipate that Danaher Co. will post 4.79 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, April 26th. Shareholders of record on Friday, March 29th will be issued a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 0.53%. The ex-dividend date of this dividend is Thursday, March 28th. This is an increase from Danaher’s previous quarterly dividend of $0.16. Danaher’s dividend payout ratio (DPR) is currently 15.04%.
Several research firms have issued reports on DHR. Zacks Investment Research upgraded Danaher from a “hold” rating to a “buy” rating and set a $147.00 target price on the stock in a research note on Tuesday, April 9th. Needham & Company LLC reiterated a “buy” rating and issued a $138.00 target price (up previously from $114.00) on shares of Danaher in a research note on Thursday, February 28th. Jefferies Financial Group lifted their target price on Danaher to $140.00 and gave the company a “buy” rating in a research note on Tuesday, February 26th. Deutsche Bank lifted their target price on Danaher to $130.00 and gave the company a “buy” rating in a research note on Tuesday, February 26th. Finally, UBS Group lifted their target price on Danaher from $125.00 to $144.00 and gave the company a “buy” rating in a research note on Tuesday, February 26th. One equities research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $125.46.
In other Danaher news, CAO Robert S. Lutz sold 17,822 shares of the firm’s stock in a transaction dated Wednesday, February 27th. The stock was sold at an average price of $126.95, for a total value of $2,262,502.90. Following the completion of the sale, the chief accounting officer now owns 22,251 shares of the company’s stock, valued at $2,824,764.45. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, SVP Angela S. Lalor sold 4,534 shares of the firm’s stock in a transaction dated Wednesday, February 27th. The stock was sold at an average price of $127.25, for a total value of $576,951.50. Following the completion of the sale, the senior vice president now directly owns 21,209 shares of the company’s stock, valued at approximately $2,698,845.25. The disclosure for this sale can be found here. In the last three months, insiders sold 183,150 shares of company stock valued at $23,279,637. Corporate insiders own 11.40% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “BTIM Corp. Increases Stake in Danaher Co. (DHR)” was reported by Macon Daily and is owned by of Macon Daily. If you are accessing this report on another publication, it was copied illegally and republished in violation of U.S. & international copyright and trademark law. The original version of this report can be read at https://macondaily.com/2019/04/17/btim-corp-increases-stake-in-danaher-co-dhr.html.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Recommended Story: Are analyst ratings accurate?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.